New drug shows promise for diabetic kidney damage
Disease control
Completed
This study tested a new medicine called CU01-1001 in 240 adults with type 2 diabetes and early kidney damage (protein in urine). Participants took the drug or a placebo for 24 weeks. The main goal was to see if the drug could lower the amount of protein leaking into urine, a sign…
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC